Lisata Therapeutics Statistics

Total Valuation

Lisata Therapeutics has a market cap or net worth of GBP 18.74 million. The enterprise value is -10.43 million.

Market Cap	18.74M
Enterprise Value	-10.43M

Important Dates

The next estimated earnings date is Wednesday, March 26, 2025.

Earnings Date	Mar 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.19%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	6.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.67
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.03, with a Debt / Equity ratio of 0.01.

Current Ratio	8.03
Quick Ratio	7.64
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -48.15% and return on invested capital (ROIC) is -33.87%.

Return on Equity (ROE)	-48.15%
Return on Assets (ROA)	-30.49%
Return on Capital (ROIC)	-33.87%
Revenue Per Employee	n/a
Profits Per Employee	-618,965
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +33.36% in the last 52 weeks. The beta is 1.22, so Lisata Therapeutics's price volatility has been higher than the market average.

Beta (5Y)	1.22
52-Week Price Change	+33.36%
50-Day Moving Average	3.14
200-Day Moving Average	3.25
Relative Strength Index (RSI)	65.53
Average Volume (20 Days)	1,324

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-17.52M
Pretax Income	-16.07M
Net Income	-15.47M
EBITDA	-17.39M
EBIT	-17.52M
Earnings Per Share (EPS)	-1.87

Full Income Statement

Balance Sheet

The company has 26.75 million in cash and 135,044 in debt, giving a net cash position of 26.62 million.

Cash & Cash Equivalents	26.75M
Total Debt	135,044
Net Cash	26.62M
Net Cash Per Share	n/a
Equity (Book Value)	24.95M
Book Value Per Share	3.02
Working Capital	24.62M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-14.10M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Lisata Therapeutics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.19%
Shareholder Yield	-3.19%
Earnings Yield	-82.55%
FCF Yield	n/a

Stock Splits

The last stock split was on September 15, 2022. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Sep 15, 2022
Split Type	Reverse
Split Ratio	0.0666666667

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a